Discovery strategies in a pharmaceutical setting: The application of computational techniques

Expert Opinion on Drug Discovery

Volumn 1, Issue 7, 2006, Pages 709-721

  Jennings, Andy ^a   Tennant, Mike ^a  

^a Takeda San Diego Inc   (United States)

Author keywords

electrostatics; fingerprints; focused array; high throughput docking

Indexed keywords

EID: 42249106492     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.1.7.709     Document Type: Review

References (33)

1. JENNINGS A, TENNANT M: Discovery strategies in a biopharmaceutical startup: maximising your chances of success using computational filters. Curr. Pharm. Des. (2005) 11(3):335-344.
2. BAJORATH J: Chemoinformatics methods for systematic comparison of molecules from natural and synthetic sources and design of hydrid libraries. Mol. Divers. (2002) 5(4):305-313.
3. MESTRES J: Virtual screening: a real screening complement to high-throughput screening. Biochem. Soc. Trans. (2002) 30(4):797-799.
4. LAJINESS MS, MAGGIORA GM, SHANMUGASUNDARAM V et al.: Assessment of the consistency of medicinal chemists in reviewing sets of compounds. J. Med. Chem. (2004) 47:4891-4896.
5. LIPINSKI CA, LOMBARDO F, DOMINY BW, FEENEY PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. (1997) 23:3-26.
6. OLAH MM, BOLOGA CG, OPREA TI: Strategies for compound selection. Curr. Drug Discov. Technol. (2004) 1(3):211-220.
7. STAHURA FL, BAJORATH J: New methodologies for ligand-based virtual screening. Curr. Pharm. Des. (2005) 11(9):1189-1202.
8. JAIN AN: Virtual screening in lead discovery and optimisation. Curr. Opin. Drug Discov. Devel. (2004) 7(4):396-403.
9. OLESEN PH: The use of bioisosteric groups in lead optimisation. Curr. Opin. Drug Discov. Devel. (2001) 4(4):471-478.
10. WAGENER M, LOMMERSE JP: The quest for bioisosteric replacements. J. Chem. Inf. Model. (2006) 46(2):677-685.
11. SCHUFFENHAUER A, GILLET VJ, WILLETT P: Similarity searching in files of three-dimensional chemical structures: analysis of the BIOSTER database using two-dimensional fingerprints and molecular field descriptors. J. Chem. Inf. Comput. Sci. (2000) 40(2):295-307.
12. BOSTRÖM J: Reproducing the conformations of protein-bound ligands: a critical evaluation of several popular conformational searching tools. J. Comp.-Aid. Mol. Des. (2001) 15:1137.
13. GRANT JA, GALLARDO MA, PICKUP BT: A fast method of molecular shape comparison. A simple application of a Gaussian description of molecular shape. J. Comp. Chem. (1996) 17:1653-1666.
14. HAIGH JA, PICKUP BT, GRANT JA, NICHOLLS A: Small molecule shape-fingerprints. J. Chem. Inf. Model. (2005) 45(3):673-684.
15. NICHOLLS A, MACCUISH NE, MACCUISH JD: Variable selection and model validation of 2-D and 3-D molecular descriptors. J. Comp.-Aided Mol. Des. (2004) 18:451-474.
16. NICHOLLS A, GRANT AJ: Molecular shape and electrostatics in the encoding of relevant chemical information. J. Comp.-Aid. Mol. Des. (2005) 19(9-10):661-686.
17. CLARK T: QSAR and QSPR based solely on surface properties? J. Mol. Graph. Model. (2004) 22:519-525.
18. MUCHMORE S: The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist. Chem. Biol. Drug Des. (2006) 67:174-176.
19. SHUKER SB, HAJDUK PJ, MEADOWS RP, FESIK SW: Discovering high-affinity ligands for proteins: SAR by NMR. Science (1996) 274(5292):1531-1534.
20. LESUISSE D, LANGE G, DEPREZ P et al.: SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2. J. Med. Chem. (2002) 45(12):2379-2387.
21. LIGHTFOOT T, ELLIS SW, MAHLING J et al.: Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling. Xenobiotica (2000) 30(3):219-233.
22. LABUTE P: Binary QSAR: a new method for the determination of quantitative structure activity relationships. Pac. Symp. Biocomput. (1999) 4:444-455.
23. XIA X, MALISKI EG, GALLANT P, ROGERS D: Classification of kinase inhibitors using a bayesian model. J. Med. Chem. (2004) 47(18):4463-4470.
24. LIVINGSTONE DJ, SALT DW: Judging the significance of multiple linear regression models. J. Med. Chem. (2005) 48(3):661-663.
25. LENGAUER T, RAREY M: Computational methods for biomolecular docking. Curr. Opin. Struct. Biol. (1996) 6(3):402-406.
26. GEHLHAAR DK, VERKHIVER GM, REIJTO PA et al.: Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. Chem. Biol. (1995) 2:317-324.
27. http://www.daylight.com/products/ toolkit.html Daylight CIS, Inc.
28. http://www.eyesopen.com OpenEye Scientific Software, Inc.
29. http://www.cs.waikato.ac.nz/ml/weka/ MILK: a Multi-Instance Learning Kit in Java.
30. http://www.metaphorics.com Metaphorics, LLC.
31. http://gaul.sourceforge.net. GAUL: a programming library designed to aid in the development of applications that use genetic or evolutionary algorithms.
32. http://www.chemcomp.com Chemical Computing Group.
33. http://www.ccdc.cam.ac.uk/products/life-sciences/gold/ GOLD. CCDC website.